Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 6
Results: 25
Acquired hemophilia A following SARS CoV-2 mRNA vaccine: Correspondence.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Real-world management of targeted therapies in chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1411, doi. 10.1177/10781552221090869
- By:
- Publication type:
- Article
Expanding oncology pharmacist teams: Justifying the return on investment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1381, doi. 10.1177/10781552221086292
- By:
- Publication type:
- Article
Belantamab mafodotin for relapsed or refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1375, doi. 10.1177/10781552221086265
- By:
- Publication type:
- Article
Management of Myeloproliferative Neoplasms (MPNs).
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1400, doi. 10.1177/10781552221082293
- By:
- Publication type:
- Article
Vitamin E and levocarnitine as prophylaxis against doxorubicin-induced cardio toxicity in the adult cancer patient: A review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1388, doi. 10.1177/10781552221078284
- By:
- Publication type:
- Article
Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1478, doi. 10.1177/10781552221077051
- By:
- Publication type:
- Article
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1474, doi. 10.1177/10781552221076756
- By:
- Publication type:
- Article
Gefitinib induced Pemphigus Vulgaris with PRIDE complex.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1465, doi. 10.1177/10781552221076755
- By:
- Publication type:
- Article
Unexpected severe hepatic and skin toxicities during high dose methotrexate course for osteosarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1458, doi. 10.1177/10781552221076456
- By:
- Publication type:
- Article
Successful desensitization under antihistamine suppression in a case with urticaria due to osimertinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1454, doi. 10.1177/10781552221075809
- By:
- Publication type:
- Article
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1450, doi. 10.1177/10781552221075545
- By:
- Publication type:
- Article
Docetaxel monotherapy induces necrotic acute pancreatitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1446, doi. 10.1177/10781552221075541
- By:
- Publication type:
- Article
Complete metabolic response after carboplatin desensitization in Peritoneal Carcinomatosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1441, doi. 10.1177/10781552221074975
- By:
- Publication type:
- Article
The drugs screened by OncoVee TM -Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1435, doi. 10.1177/10781552221074973
- By:
- Publication type:
- Article
The role of the clinical pharmacist in guiding adjuvant hormonal therapy in patients with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1368, doi. 10.1177/10781552211029361
- By:
- Publication type:
- Article
Awareness of pharmacists and consumers towards protective effects of sunscreens against skin cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1363, doi. 10.1177/10781552211029358
- By:
- Publication type:
- Article
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1357, doi. 10.1177/10781552211029046
- By:
- Publication type:
- Article
Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1350, doi. 10.1177/10781552211027339
- By:
- Publication type:
- Article
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1340, doi. 10.1177/10781552211024727
- By:
- Publication type:
- Article
Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1332, doi. 10.1177/10781552211024723
- By:
- Publication type:
- Article
A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1326, doi. 10.1177/10781552211021147
- By:
- Publication type:
- Article
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1315, doi. 10.1177/10781552211020815
- By:
- Publication type:
- Article
Shared decision-making and patient decision aids in choosing first-line targeted therapy for metastatic colorectal cancer in Taiwan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1293, doi. 10.1177/10781552211020806
- By:
- Publication type:
- Article
Stability of calcium levofolinate, 5-fluorouracil and oxaliplatin (FOLFOX) mixture.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1303, doi. 10.1177/10781552211020808
- By:
- Publication type:
- Article